SHIP cluster U-turns on Lucentis policy after price is slashed

By Sarah Calkin2012-07-27T12:13:00

A primary care trust cluster under the threat of legal action for recommending the use of an unlicensed drug has revoked the policy after the pharmaceutical company cut the price of the medicine.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
10 expert briefings every fortnight (Premium only)

to HSJ

Already a subscriber? Sign into your account here